{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T13:29:23Z","timestamp":1789046963354,"version":"build-2803163510"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["OBES SURG"],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Metabolic dysfunction-associated steatotic liver disease (MASLD), a leading cause of chronic liver disease in the United States, is linked to obesity and insulin resistance. Endoscopic gastric remodeling (EGR) offers a safe and effective minimally invasive approach for MASLD. It is associated with improvements in noninvasive fibrosis test (NIT), liver enzymes, weight reduction, and metabolic parameters than bariatric surgery in the management of obesity. EGR includes three primary approaches: endoscopic sleeve gastroplasty (ESG), endoscopic gastric plication (EGP), and primary obesity surgery endoluminal (POSE).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>To evaluate the effects of EGR on MASLD-related liver outcomes and metabolic parameters.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A systematic search of multiple electronic databases, including conference proceedings, was conducted from database inception through November 2025 to identify studies reporting hepatic or metabolic outcomes following EGR. Weighted mean differences and pooled proportions were calculated using a fixed-effects model. Heterogeneity was assessed using Cochran\u2019s Q test. Primary outcomes included changes in noninvasive fibrosis indices: NAFLD Fibrosis Score (NFS), fibrosis-4 (FIB-4), and hepatic steatosis index (HSI). Secondary outcomes included liver enzymes, weight loss metrics, and glycemic parameters.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Six studies comprising 220 patients (mean age 45 years; 67.5% female; mean baseline body mass index 38.9\u00a0kg\/m\u00b2) with follow-up ranging from 6 to 12 months. EGR was associated with significant improvements in liver fibrosis indices, including NFS (mean difference\u2009\u2212\u20090.65; 95% CI\u2009\u2212\u20090.89 to \u2212\u20090.42), FIB-4 (mean difference\u2009\u2212\u20090.07; 95% CI\u2009\u2212\u20090.22 to 0.07), and HSI (reduced from 50.36\u2009\u00b1\u20093.00 to 42.66\u2009\u00b1\u20092.38). Reductions in liver enzymes were observed, with pooled decreases of 14.39 U\/L in alanine aminotransferase and 6.58 U\/L in aspartate aminotransferase. EGR resulted in weight loss, with a pooled percent excess weight loss of 47.80% and a percent total weight loss of 16.24%. Glycemic control improved, with a 0.33% reduction in hemoglobin A1c and a 62% decrease in insulin resistance. No significant publication bias was detected (Begg\u2013Mazumdar Kendall\u2019s tau b\u2009\u2212\u20090.20,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.48).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Endoscopic gastric remodeling is a safe and effective minimally invasive therapy for MASLD. Further long-term studies are warranted to confirm the durability of these benefits.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11695-026-08889-7","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T07:24:26Z","timestamp":1786433066000},"page":"4871-4881","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Short-Term Impact of Endoscopic Gastric Remodeling in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Systematic Review and Meta-Analysis"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-9062-2484","authenticated-orcid":false,"given":"Yusuf","family":"Kagzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abuzar","family":"Asif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinivas Reddy","family":"Puli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,11]]},"reference":[{"issue":"1","key":"8889_CR1","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","volume":"73","author":"M Eslam","year":"2020","unstructured":"Eslam M, Newsome PN, Sarin SK, Anstee QM, Targher G, Romero-Gomez M, Zelber-Sagi S, Wai-Sun Wong V, Dufour JF, Schattenberg JM, Kawaguchi T, Arrese M, Valenti L, Shiha G, Tiribelli C, Yki-J\u00e4rvinen H, Fan JG, Gr\u00f8nb\u00e6k H, Yilmaz Y, Cortez-Pinto H, Oliveira CP, Bedossa P, Adams LA, Zheng MH, Fouad Y, Chan WK, Mendez-Sanchez N, Ahn SH, Castera L, Bugianesi E, Ratziu V, George J. A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement. J Hepatol. 2020;73(1):202\u20139. https:\/\/doi.org\/10.1016\/j.jhep.2020.03.039 . Epub 2020 Apr 8. PMID: 32278004.","journal-title":"J Hepatol"},{"issue":"5","key":"8889_CR2","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1111\/hepr.13706","volume":"52","author":"T Kawaguchi","year":"2022","unstructured":"Kawaguchi T, Tsutsumi T, Nakano D, Torimura T. MAFLD: Renovation of clinical practice and disease awareness of fatty liver. Hepatol Res. 2022;52(5):422\u201332. https:\/\/doi.org\/10.1111\/hepr.13706 . Epub 2021 Sep 17. PMID: 34472683.","journal-title":"Hepatol Res"},{"issue":"1","key":"8889_CR3","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/CM9.0000000000001263","volume":"134","author":"YX Xian","year":"2020","unstructured":"Xian YX, Weng JP, Xu F. MAFLD vs. NAFLD: shared features and potential changes in epidemiology, pathophysiology, diagnosis, and pharmacotherapy. Chin Med J (Engl). 2020;134(1):8\u201319. PMID: 33323806; PMCID: PMC7862804.","journal-title":"Chin Med J (Engl)"},{"issue":"4","key":"8889_CR4","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1007\/s13105-023-00954-4","volume":"79","author":"P Sangro","year":"2023","unstructured":"Sangro P, de la Torre Al\u00e1ez M, Sangro B, D\u2019Avola D. Metabolic dysfunction-associated fatty liver disease (MAFLD): an update of the recent advances in pharmacological treatment. J Physiol Biochem. 2023;79(4):869\u201379. https:\/\/doi.org\/10.1007\/s13105-023-00954-4 . Epub 2023 Mar 28. PMID: 36976456; PMCID: PMC10635944.","journal-title":"J Physiol Biochem"},{"issue":"3","key":"8889_CR5","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1002\/hep.24452","volume":"54","author":"R Hernaez","year":"2011","unstructured":"Hernaez R, Lazo M, Bonekamp S, Kamel I, Brancati FL, Guallar E, Clark JM. Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis. Hepatology. 2011;54(3):1082\u201390. https:\/\/doi.org\/10.1002\/hep.24452 . PMID: 21618575; PMCID: PMC4197002.","journal-title":"Hepatology"},{"issue":"3","key":"8889_CR6","doi-asserted-by":"publisher","first-page":"245","DOI":"10.7861\/clinmedicine.18-3-245","volume":"18","author":"J Maurice","year":"2018","unstructured":"Maurice J, Manousou P. Non-alcoholic fatty liver disease. Clin Med (Lond). 2018;18(3):245\u201350. https:\/\/doi.org\/10.7861\/clinmedicine.18-3-245 . PMID: 29858436; PMCID: PMC6334080.","journal-title":"Clin Med (Lond)"},{"issue":"7","key":"8889_CR7","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/j.jdiacomp.2016.05.014","volume":"30","author":"I Mikolasevic","year":"2016","unstructured":"Mikolasevic I, Milic S, Orlic L, Stimac D, Franjic N, Targher G. Factors associated with significant liver steatosis and fibrosis as assessed by transient elastography in patients with one or more components of the metabolic syndrome. J Diabetes Complications. 2016;30(7):1347\u201353. .","journal-title":"J Diabetes Complications"},{"issue":"2","key":"8889_CR8","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1136\/jim-2018-000864","volume":"67","author":"F Bril","year":"2019","unstructured":"Bril F, McPhaul MJ, Caulfield MP, Castille JM, Poynard T, Soldevila-Pico C, Clark VC, Firpi-Morell RJ, Lai J, Cusi K. Performance of the SteatoTest, ActiTest, NashTest and FibroTest in a multiethnic cohort of patients with type 2 diabetes mellitus. J Investig Med. 2019;67(2):303\u201311. Epub 2018 Oct 10. PMID: 30309884; PMCID: PMC6581087. 000864.","journal-title":"J Investig Med"},{"issue":"1","key":"8889_CR9","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jhep.2015.04.006","volume":"63","author":"European Association for Study of Liver","year":"2015","unstructured":"European Association for Study of Liver. Asociacion Latinoamericana para el Estudio del Higado. EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis. J Hepatol. 2015;63(1):237\u201364. Epub 2015 Apr 21. PMID: 25911335.","journal-title":"J Hepatol"},{"issue":"6","key":"8889_CR10","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.jhepr.2019.10.008","volume":"1","author":"K Hallsworth","year":"2019","unstructured":"Hallsworth K, Adams LA. Lifestyle modification in NAFLD\/NASH: Facts and figures. JHEP Rep. 2019;1(6):468\u201379. https:\/\/doi.org\/10.1016\/j.jhepr.2019.10.008 . PMID: 32039399; PMCID: PMC7005657.","journal-title":"JHEP Rep"},{"issue":"12","key":"8889_CR11","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1136\/gut.2006.112094","volume":"56","author":"SA Harrison","year":"2007","unstructured":"Harrison SA, Day CP. Benefits of lifestyle modification in NAFLD. Gut. 2007;56(12):1760\u20139. https:\/\/doi.org\/10.1136\/gut.2006.112094 . Epub 2007 Oct 2. PMID: 17911352; PMCID: PMC2095707.","journal-title":"Gut"},{"issue":"3","key":"8889_CR12","doi-asserted-by":"publisher","first-page":"CD011640","DOI":"10.1002\/14651858.CD011640.pub2","volume":"3","author":"R Lombardi","year":"2017","unstructured":"Lombardi R, Onali S, Thorburn D, Davidson BR, Gurusamy KS, Tsochatzis E. Pharmacological interventions for non-alcohol related fatty liver disease (NAFLD): an attempted network meta-analysis. Cochrane Database Syst Rev. 2017;3(3):CD011640. https:\/\/doi.org\/10.1002\/14651858.CD011640.pub2 . PMID: 28358980; PMCID: PMC6464620.","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"8889_CR13","doi-asserted-by":"publisher","first-page":"824","DOI":"10.3390\/biom12060824","volume":"12","author":"FNAFLD Nassir","year":"2022","unstructured":"Nassir FNAFLD. Mechanisms, Treatments, and Biomarkers. Biomolecules. 2022;12(6):824. https:\/\/doi.org\/10.3390\/biom12060824 . PMID: 35740949; PMCID: PMC9221336.","journal-title":"Biomolecules"},{"issue":"3","key":"8889_CR14","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1007\/s11695-018-3593-1","volume":"29","author":"R Welbourn","year":"2019","unstructured":"Welbourn R, Hollyman M, Kinsman R, Dixon J, Liem R, Ottosson J, Ramos A, V\u00e5ge V, Al-Sabah S, Brown W, Cohen R, Walton P. Himpens. Bariatric surgery worldwide: baseline demographic description and one-year outcomes from the fourth IFSO global registry report 2018. J Obes Surg. 2019;29(3):782\u201395. . https:\/\/doi.org\/10.1007\/s11695-018-3593-1","journal-title":"J Obes Surg"},{"key":"8889_CR15","doi-asserted-by":"publisher","unstructured":"Adams TD, Gress RE, Smith SC, Halverson RC, Simper SC, Rosamond WD, Lamonte MJ, Stroup AM, Hunt SC. Long-term mortality after gastric bypass surgery. N Engl J Med. 2007;357(8):753\u201361. https:\/\/doi.org\/10.1056\/NEJMoa066603","DOI":"10.1056\/NEJMoa066603"},{"issue":"6","key":"8889_CR16","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1007\/s11695-016-2152-x","volume":"26","author":"M Lauti","year":"2016","unstructured":"Lauti M, Kularatna M, Hill AG, MacCormick AD. Weight regain following sleeve gastrectomy-a systematic review. Obes Surg. 2016;26(6):1326\u201334. https:\/\/doi.org\/10.1007\/s11695-016-2152-x","journal-title":"Obes Surg"},{"issue":"5","key":"8889_CR17","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.jviscsurg.2013.08.008","volume":"150","author":"JM Catheline","year":"2013","unstructured":"Catheline JM, Fysekidis M, Bachner I, Bihan H, Kassem A, Dbouk R, Bdeoui N, Boschetto A, Cohen R. Five-year results of sleeve gastrectomy. J Visc Surg. 2013;150(5):307\u201312. Epub 2013 Sep 21. PMID: 24060743.","journal-title":"J Visc Surg"},{"issue":"3","key":"8889_CR18","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1001\/jamasurg.2013.3654","volume":"149","author":"SH Chang","year":"2014","unstructured":"Chang SH, Stoll CR, Song J, Varela JE, Eagon CJ, Colditz GA. The effectiveness and risks of bariatric surgery: an updated systematic review and meta-analysis, 2003\u20132012. JAMA Surg. 2014;149(3):275\u201387. PMID: 24352617; PMCID: PMC3962512.","journal-title":"JAMA Surg"},{"issue":"9","key":"8889_CR19","doi-asserted-by":"publisher","first-page":"2917","DOI":"10.1007\/s11695-023-06747-4","volume":"33","author":"BCM Nunes","year":"2023","unstructured":"Nunes BCM, de Moura DTH, Kum AST, de Oliveira GHP, Hirsch BS, Ribeiro IB, Gomes ILC, de Oliveira CPM, Mahmood S, Bernardo WM, de Moura EGH. Impact of Endoscopic Sleeve Gastroplasty in Non-alcoholic Fatty Liver Disease: a Systematic Review and Meta-analysis. Obes Surg. 2023;33(9):2917\u201326. https:\/\/doi.org\/10.1007\/s11695-023-06747-4 . Epub 2023 Aug 4. PMID: 37537506.","journal-title":"Obes Surg"},{"issue":"1","key":"8889_CR20","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.tgie.2016.12.004","volume":"19","author":"BA Dayyeh","year":"2017","unstructured":"Dayyeh BA, Rajan E, Gostout CJ. Gastric endoscopic remodeling techniques. Techniques Gastrointest Endoscopy. 2017;19(1):22\u20136.","journal-title":"Techniques Gastrointest Endoscopy"},{"key":"8889_CR21","first-page":"2007","volume":"16","author":"MT Dorak","year":"2007","unstructured":"Dorak MT. Common concepts in statistics. Retrieved Dec. 2007;16:2007.","journal-title":"Retrieved Dec"},{"issue":"3","key":"8889_CR22","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177\u201388. 10.1016\/0197\u20132456(86)90046\u20132. PMID: 3802833.","journal-title":"Control Clin Trials"},{"key":"8889_CR23","first-page":"285","volume-title":"Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis, 2nd","author":"JJ Deeks","year":"2001","unstructured":"Deeks JJ, Altman DG, Bradburn MJ, et al. Systematic reviews in health care: meta-analysis in context. Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis, 2nd. London: BMJ Publication Group; 2001. pp. 285\u2013312."},{"key":"8889_CR24","doi-asserted-by":"publisher","unstructured":"Harbord RM, Egger M, Sterne JA. A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints. Stat Med. 2006;25(20):3443\u201357. https:\/\/doi.org\/10.1002\/sim.2380","DOI":"10.1002\/sim.2380"},{"issue":"4","key":"8889_CR25","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.2307\/2533446","volume":"50","author":"CB Begg","year":"1994","unstructured":"Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50(4):1088\u2013101. PMID: 7786990.","journal-title":"Biometrics"},{"issue":"7304","key":"8889_CR26","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1136\/bmj.323.7304.101","volume":"323","author":"JA Sterne","year":"2001","unstructured":"Sterne JA, Egger M, Smith GD. Systematic reviews in health care: Investigating and dealing with publication and other biases in meta-analysis. BMJ. 2001;323(7304):101\u20135. https:\/\/doi.org\/10.1136\/bmj.323.7304.101 . PMID: 11451790; PMCID: PMC1120714.","journal-title":"BMJ"},{"issue":"10","key":"8889_CR27","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/s0895-4356","volume":"54","author":"JA Sterne","year":"2001","unstructured":"Sterne JA, Egger M. Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. J Clin Epidemiol. 2001;54(10):1046\u201355. https:\/\/doi.org\/10.1016\/s0895-4356. (01)00377\u20138. PMID: 11576817.","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"8889_CR28","doi-asserted-by":"publisher","first-page":"283","DOI":"10.17235\/reed.2019.5949\/2018","volume":"111","author":"E Espinet Coll","year":"2019","unstructured":"Espinet Coll E, Vila Lolo C, D\u00edaz Gal\u00e1n P, G\u00f3mez Valero JA, Bacchiddu S, Quintana Tom\u00e1s C, Irigoyen D, Gunnard K, Juan-Creix Comamala A. Bariatric and metabolic endoscopy in the handling of fatty liver disease. A new emerging approach? Rev Esp Enferm Dig. 2019;111(4):283\u201393. https:\/\/doi.org\/10.17235\/reed.2019.5949\/2018","journal-title":"Rev Esp Enferm Dig"},{"issue":"5","key":"8889_CR29","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/j.gie.2020.08.023","volume":"93","author":"K Hajifathalian","year":"2021","unstructured":"Hajifathalian K, Mehta A, Ang B, Skaf D, Shah SL, Saumoy M, Dawod Q, Dawod E, Shukla A, Aronne L, Brown RS, Cohen DE, Dannenberg AJ, Fortune B, Kumar S, Sharaiha RZ. Improvement in insulin resistance and estimated hepatic steatosis and fibrosis after endoscopic sleeve gastroplasty. Gastrointest Endosc. 2021;93(5):1110\u20138. Epub 2020 Aug 27. PMID: 32861753.","journal-title":"Gastrointest Endosc"},{"issue":"6","key":"8889_CR30","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1007\/s12664-021-01202-7","volume":"40","author":"N Jagtap","year":"2021","unstructured":"Jagtap N, Kalapala R, Katakwar A, Sharma M, Aslam M, Gupta R, Rao PN, Goud R, Tandan M, Kanakagiri H, Darishetty S, Reddy DN. Endoscopic sleeve gastroplasty - minimally invasive treatment for non-alcoholic fatty liver disease and obesity. Indian J Gastroenterol. 2021;40(6):572\u20139. https:\/\/doi.org\/10.1007\/s12664-021-01202-7 . Epub 2021 Dec 16. PMID: 34914039.","journal-title":"Indian J Gastroenterol"},{"issue":"6","key":"8889_CR31","doi-asserted-by":"publisher","first-page":"983","DOI":"10.14309\/ajg.0000000000002087","volume":"118","author":"P Jirapinyo","year":"2023","unstructured":"Jirapinyo P, Zucker SD, Thompson CC. Regression of Hepatic Fibrosis After Endoscopic Gastric Plication in Nonalcoholic Fatty Liver Disease. Am J Gastroenterol. 2023;118(6):983\u201390. https:\/\/doi.org\/10.14309\/ajg.0000000000002087 . Epub 2022 Dec 23. PMID: 36597405.","journal-title":"Am J Gastroenterol"},{"issue":"11","key":"8889_CR32","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1055\/a-2117","volume":"55","author":"M AlKhatry","year":"2023","unstructured":"AlKhatry M, Rapaka B, Maselli DB, Abboud DM, Brunaldi VO, Mahmoud T, Ghazi R, Abdul Razzak F, Gala K, Joudah I, Housen F, Al Qadi S, Vargas EJ, Storm AC, Abu Dayyeh BK. Improvements in hepatic steatosis, obesity, and insulin resistance in adults with nonalcoholic fatty liver disease after the primary obesity surgery endoluminal 2.0 procedure. Endoscopy. 2023;55(11):1028\u201334. https:\/\/doi.org\/10.1055\/a-2117. Epub 2023 Jun 26. PMID: 37364600.","journal-title":"Endoscopy"},{"key":"8889_CR33","doi-asserted-by":"crossref","unstructured":"Kolb JM, Rapaka B, Abu Dayyeh BK, Chang KJ. Endoscopic gastric remodeling for weight loss. In: The AFS textbook of foregut disease. Cham: Springer International Publishing; 2023. pp. 535\u201343","DOI":"10.1007\/978-3-031-19671-3_55"},{"issue":"3","key":"8889_CR34","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1007\/s13679-024-00574-z","volume":"13","author":"F Abdelhameed","year":"2024","unstructured":"Abdelhameed F, Kite C, Lagojda L, Dallaway A, Chatha KK, Chaggar SS, Dalamaga M, Kassi E, Kyrou I, Randeva HS. Non-invasive Scores and Serum Biomarkers for Fatty Liver in the Era of Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD): A Comprehensive Review From NAFLD to MAFLD and MASLD. Curr Obes Rep. 2024;13(3):510\u201331. https:\/\/doi.org\/10.1007\/s13679-024-00574-z.","journal-title":"Curr Obes Rep"},{"issue":"3","key":"8889_CR35","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3727\/105221619X15553433838609","volume":"19","author":"JZ Zhang","year":"2019","unstructured":"Zhang JZ, Cai JJ, Yu Y, She ZG, Li H. Nonalcoholic Fatty Liver Disease: An Update on the Diagnosis. Gene Expr. 2019;19(3):187\u201398. https:\/\/doi.org\/10.3727\/105221619X15553433838609 . Epub 2019 Apr 22. PMID: 31010457; PMCID: PMC6827037.","journal-title":"Gene Expr"},{"issue":"1","key":"8889_CR36","doi-asserted-by":"publisher","first-page":"98","DOI":"10.3390\/diagnostics11010098","volume":"11","author":"S Ballestri","year":"2021","unstructured":"Ballestri S, Mantovani A, Baldelli E, Lugari S, Maurantonio M, Nascimbeni F, Marrazzo A, Romagnoli D, Targher G, Lonardo A. Liver Fibrosis Biomarkers Accurately Exclude Advanced Fibrosis and Are Associated with Higher Cardiovascular Risk Scores in Patients with NAFLD or Viral Chronic Liver Disease. Diagnostics (Basel). 2021;11(1):98. https:\/\/doi.org\/10.3390\/diagnostics11010098 . PMID: 33435415; PMCID: PMC7827076.","journal-title":"Diagnostics (Basel)"},{"issue":"4","key":"8889_CR37","doi-asserted-by":"publisher","first-page":"589","DOI":"10.14218\/JCTH.2021.00311","volume":"10","author":"X Chen","year":"2022","unstructured":"Chen X, Goh GB, Huang J, Wu Y, Wang M, Kumar R, Lin S, Zhu Y. Validation of Non-invasive Fibrosis Scores for Predicting Advanced Fibrosis in Metabolic-associated Fatty Liver Disease. J Clin Transl Hepatol. 2022;10(4):589\u201394. Epub 2022 Jan 12. PMID: 36062270; PMCID: PMC9396333.","journal-title":"J Clin Transl Hepatol"},{"issue":"2","key":"8889_CR38","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1053\/j.gastro.2015.04.005","volume":"149","author":"E Vilar-Gomez","year":"2015","unstructured":"Vilar-Gomez E, Martinez-Perez Y, Calzadilla-Bertot L, Torres-Gonzalez A, Gra-Oramas B, Gonzalez-Fabian L, Friedman SL, Diago M, Romero-Gomez M. Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis. Gastroenterology. 2015;149(2):367\u201378.","journal-title":"Gastroenterology"},{"issue":"1","key":"8889_CR39","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1038\/s41598-025-85427-y","volume":"15","author":"A Seyedi","year":"2025","unstructured":"Seyedi A, Rabizadeh S, Reyhan SK, Hobaby S, Afshari SA, Shomalzadeh M, Nabipoorashrafi SA, Soran NA, Yadegar A, Mohammadi F, Moosaei F, Saffari E, Riazi S, Sarv F, Nakhjavani M, Pazouki A, Esteghamati A. Impact of bariatric surgery on liver fibrosis indices among type 2 diabetes patients in a national cohort. Sci Rep. 2025;15(1):1235. https:\/\/doi.org\/10.1038\/s41598-025-85427-y . PMID: 39775004; PMCID: PMC11707195.","journal-title":"Sci Rep"},{"issue":"16","key":"8889_CR40","doi-asserted-by":"publisher","first-page":"4910","DOI":"10.3390\/jcm11164910","volume":"11","author":"ECS Sandvik","year":"2022","unstructured":"Sandvik ECS, Aasar\u00f8d KM, Johnsen G, Hoff DAL, Kulseng B, Hyldmo \u00c5A, Gr\u00e6slie H, Nymo S, Sandvik J, Fossmark R. The Effect of Roux-en-Y Gastric Bypass on Non-Alcoholic Fatty Liver Disease Fibrosis Assessed by FIB\u20134 and NFS Scores-An 11.6-Year Follow-Up Study. J Clin Med. 2022;11(16):4910. https:\/\/doi.org\/10.3390\/jcm11164910 . PMID: 36013149; PMCID: PMC9409952.","journal-title":"J Clin Med"},{"issue":"10","key":"8889_CR41","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/j.cgh.2009.05.033","volume":"7","author":"AG Shah","year":"2009","unstructured":"Shah AG, Lydecker A, Murray K, Tetri BN, Contos MJ, Sanyal AJ, Nash Clinical Research Network. Use of the FIB4 index for non-invasive evaluation of fibrosis in nonalcoholic fatty liver disease. Clin Gastroenterol hepatology: official Clin Pract J Am Gastroenterological Association. 2009;7(10):1104.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"10","key":"8889_CR42","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/j.cgh.2009.05.033","volume":"7","author":"AG Shah","year":"2009","unstructured":"Shah AG, Lydecker A, Murray K, Tetri BN, Contos MJ, Sanyal AJ. Nash Clinical Research Network. Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2009;7(10):1104\u201312. .","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"8889_CR43","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1111\/liv.14669","volume":"41","author":"J Lee","year":"2021","unstructured":"Lee J, Vali Y, Boursier J, Spijker R, Anstee QM, Bossuyt PM, Zafarmand MH. Prognostic accuracy of FIB\u20134, NAFLD fibrosis score and APRI for NAFLD-related events: A systematic review. Liver Int. 2021;41(2):261\u201370. https:\/\/doi.org\/10.1111\/liv.14669 . PMID: 32946642; PMCID: PMC7898346.","journal-title":"Liver Int"},{"issue":"11","key":"8889_CR44","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.1016\/j.cgh.2021.12.034","volume":"20","author":"I Graupera","year":"2022","unstructured":"Graupera I, Thiele M, Serra-Burriel M, Caballeria L, Roulot D, Wong GL, Fabrellas N, Guha IN, Arslanow A, Exp\u00f3sito C, Hern\u00e1ndez R, Aithal GP, Galle PR, Pera G, Wong VW, Lammert F, Gin\u00e8s P, Castera L, Krag A. Investigators of the LiverScreen Consortium. Low Accuracy of FIB\u20134 and NAFLD Fibrosis Scores for Screening for Liver Fibrosis in the Population. Clin Gastroenterol Hepatol. 2022;20(11):2567\u2013e25766. https:\/\/doi.org\/10.1016\/j.cgh.2021.12.034 . Epub 2021 Dec 29. PMID: 34971806.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"28","key":"8889_CR45","doi-asserted-by":"publisher","first-page":"45768","DOI":"10.18632\/oncotarget.17470","volume":"8","author":"Q Li","year":"2017","unstructured":"Li Q, Lu C, Li W, Huang Y, Chen L. Impact of age on the diagnostic performances and cut-offs of APRI and FIB\u20134 for significant fibrosis and cirrhosis in chronic hepatitis B. Oncotarget. 2017;8(28):45768\u201376. https:\/\/doi.org\/10.18632\/oncotarget.17470 . PMID: 28514753; PMCID: PMC5542225.","journal-title":"Oncotarget"},{"issue":"7","key":"8889_CR46","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1136\/gutjnl-2018-317593","volume":"69","author":"R Loomba","year":"2020","unstructured":"Loomba R, Adams LA. Advances in non-invasive assessment of hepatic fibrosis. Gut. 2020;69(7):1343\u201352. https:\/\/doi.org\/10.1136\/gutjnl-2018-317593. Epub 2020 Feb 17. PMID: 32066623; PMCID: PMC7945956.","journal-title":"Gut"},{"issue":"20","key":"8889_CR47","doi-asserted-by":"publisher","first-page":"12489","DOI":"10.3390\/ijms232012489","volume":"23","author":"M Vigan\u00f2","year":"2022","unstructured":"Vigan\u00f2 M, Pugliese N, Cerini F, Turati F, Cimino V, Ridolfo S, Rocchetto S, Foglio F, Terrin M, La Vecchia C, Rumi MG, Aghemo A. Accuracy of FIB\u20134 to Detect Elevated Liver Stiffness Measurements in Patients with Non-Alcoholic Fatty Liver Disease: A Cross-Sectional Study in Referral Centers. Int J Mol Sci. 2022;23(20):12489. https:\/\/doi.org\/10.3390\/ijms232012489 . PMID: 36293345; PMCID: PMC9604259.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"8889_CR48","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.dld.2009.08.002","volume":"42","author":"JH Lee","year":"2010","unstructured":"Lee JH, Kim D, Kim HJ, Lee CH, Yang JI, Kim W, Kim YJ, Yoon JH, Cho SH, Sung MW, Lee HS. Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease. Dig Liver Dis. 2010;42(7):503\u20138. https:\/\/doi.org\/10.1016\/j.dld.2009.08.002. Epub 2009 Sep 18. PMID: 19766548.","journal-title":"Dig Liver Dis"},{"issue":"6","key":"8889_CR49","doi-asserted-by":"publisher","first-page":"353","DOI":"10.4174\/astr.2022.102.6.353","volume":"102","author":"KH Kim","year":"2022","unstructured":"Kim KH, Kim Y, Seo KI, Seo KW. Short-term outcome of bariatric surgery on nonalcoholic fatty liver disease: a Korean perspective. Ann Surg Treat Res. 2022;102(6):353\u20139. https:\/\/doi.org\/10.4174\/astr.2022.102.6.353 . Epub 2022 Jun 7. PMID: 35800999; PMCID: PMC9204024.","journal-title":"Ann Surg Treat Res"},{"key":"8889_CR50","doi-asserted-by":"publisher","first-page":"817","DOI":"10.17179\/excli2016-800","volume":"15","author":"MR McGill","year":"2016","unstructured":"McGill MR. The past and present of serum aminotransferases and the future of liver injury biomarkers. EXCLI J. 2016;15:817\u201328. https:\/\/doi.org\/10.17179\/excli2016-800 . PMID: 28337112; PMCID: PMC5318690.","journal-title":"EXCLI J"},{"issue":"3","key":"8889_CR51","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.soard.2015.02.003","volume":"11","author":"SA el Brethauer","year":"2015","unstructured":"Brethauer SA, Kim J, el Chaar M, Papasavas P, Eisenberg D, Rogers A, Ballem N, Kligman M, Kothari S, ASMBS Clinical Issues Committee. Standardized outcomes reporting in metabolic and bariatric surgery. Surg Obes Relat Dis. 2015;11(3):489\u2013506. .","journal-title":"Surg Obes Relat Dis"},{"issue":"1","key":"8889_CR52","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/hep.23276","volume":"51","author":"K Promrat","year":"2010","unstructured":"Promrat K, Kleiner DE, Niemeier HM, Jackvony E, Kearns M, Wands JR, Fava JL, Wing RR. Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis. Hepatology. 2010;51(1):121\u20139. PMID: 19827166; PMCID: PMC2799538.","journal-title":"Hepatology"},{"issue":"4","key":"8889_CR53","doi-asserted-by":"publisher","first-page":"E558","DOI":"10.1055\/a-1120-8350","volume":"8","author":"BP Mohan","year":"2020","unstructured":"Mohan BP, Asokkumar R, Khan SR, Kotagiri R, Sridharan GK, Chandan S, Ravikumar NP, Ponnada S, Jayaraj M, Adler DG. Outcomes of endoscopic sleeve gastroplasty; how does it compare to laparoscopic sleeve gastrectomy? A systematic review and meta-analysis. Endosc Int Open. 2020;8(4):E558\u201365. 10.1055\/a-. Epub 2020 Mar 23. PMID: 32258380; PMCID: PMC7089787.","journal-title":"Endosc Int Open"},{"issue":"1","key":"8889_CR54","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1007\/s00464-020-08267-z","volume":"36","author":"S Singh","year":"2022","unstructured":"Singh S, Bazarbashi AN, Khan A, Chowdhry M, Bilal M, de Moura DTH, Jirapinyo P, Thakkar S, Thompson CC. Primary obesity surgery endoluminal (POSE) for the treatment of obesity: a systematic review and meta-analysis. Surg Endosc. 2022;36(1):252\u201366. https:\/\/doi.org\/10.1007\/s00464-020-08267-z . Epub 2021 Feb 1. PMID: 33523277; PMCID: PMC8389059.","journal-title":"Surg Endosc"},{"key":"8889_CR55","doi-asserted-by":"publisher","first-page":"808526","DOI":"10.3389\/fendo.2021.808526","volume":"12","author":"C Zhang","year":"2021","unstructured":"Zhang C, Liu S, Yang M. Hepatocellular Carcinoma and Obesity, Type 2 Diabetes Mellitus, Cardiovascular Disease: Causing Factors, Molecular Links, and Treatment Options. Front Endocrinol (Lausanne). 2021;12:808526. https:\/\/doi.org\/10.3389\/fendo.2021.808526 . PMID: 35002979; PMCID: PMC8733382.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"9","key":"8889_CR56","doi-asserted-by":"publisher","first-page":"4495","DOI":"10.3390\/ijms22094495","volume":"22","author":"H Kim","year":"2021","unstructured":"Kim H, Lee DS, An TH, Park HJ, Kim WK, Bae KH, Oh KJ. Metabolic Spectrum of Liver Failure in Type 2 Diabetes and Obesity: From NAFLD to NASH to HCC. Int J Mol Sci. 2021;22(9):4495. https:\/\/doi.org\/10.3390\/ijms22094495 . PMID: 33925827; PMCID: PMC8123490.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"8889_CR57","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1002\/hep.31806","volume":"74","author":"AS Alexopoulos","year":"2021","unstructured":"Alexopoulos AS, Crowley MJ, Wang Y, Moylan CA, Guy CD, Henao R, Piercy DL, Seymour KA, Sudan R, Portenier DD, Diehl AM, Coviello AD, Abdelmalek MF. Glycemic Control Predicts Severity of Hepatocyte Ballooning and Hepatic Fibrosis in Nonalcoholic Fatty Liver Disease. Hepatology. 2021;74(3):1220\u201333. Epub 2021 Jun 2. PMID: 33724511; PMCID: PMC8518519.","journal-title":"Hepatology"},{"key":"8889_CR58","doi-asserted-by":"publisher","unstructured":"Liu H, Lefere S, Guillot A, Zheng MH, Tacke F. Bariatric surgery for metabolic dysfunction-associated steatotic liver disease (MASLD): current knowledge of mechanisms. Hepatology. 2025. https:\/\/doi.org\/10.1097\/HEP.0000000000001417","DOI":"10.1097\/HEP.0000000000001417"},{"issue":"10","key":"8889_CR59","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1007\/s11695-015-1657-z","volume":"25","author":"L Angrisani","year":"2015","unstructured":"Angrisani L, Santonicola A, Iovino P, Formisano G, Buchwald H, Scopinaro N. Bariatric surgery worldwide 2013. Obes Surg. 2015;25(10):1822\u201332. https:\/\/doi.org\/10.1007\/s11695-015-1657-z","journal-title":"Obes Surg"}],"container-title":["Obesity Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11695-026-08889-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11695-026-08889-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11695-026-08889-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T12:55:03Z","timestamp":1789044903000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11695-026-08889-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,11]]},"references-count":59,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["8889"],"URL":"https:\/\/doi.org\/10.1007\/s11695-026-08889-7","relation":{},"ISSN":["0960-8923","1708-0428"],"issn-type":[{"value":"0960-8923","type":"print"},{"value":"1708-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,11]]},"assertion":[{"value":"14 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","label":"Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}